SHIRE PLC
|
|||
By:
|
/s/ A C Russell |
|
|
Name: | Angus Russell |
|
|
Title: | Chief Executive Officer |
|
EXHIBIT INDEX
|
|
Number
|
Description
|
99.01
|
Press release dated March 4, 2013
|
Press Release
www.shire.com
|
![]() |
Type of Security(1)
|
No of Ordinary Shares/ADSs
|
Exercise price
|
|
Flemming Ornskov(2)
|
ADSs
|
45,601
|
$95.04
|
Graham Hetherington(2)
|
Ordinary Shares
|
66,708
|
£20.88
|
Jeffrey Jonas
|
ADSs
|
6,291
|
$95.04
|
Tatjana May
|
Ordinary Shares
|
22,489
|
£20.88
|
Type of Security(1)
|
No of Ordinary Shares/ADSs
|
|
Flemming Ornskov(2)
|
ADSs
|
34,201
|
Graham Hetherington(2)
|
Ordinary Shares
|
48,919
|
Jeffrey Jonas
|
ADSs
|
4,529
|
Tatjana May
|
Ordinary Shares
|
16,192
|
Number of ADSs released(4)
|
Number of ADSs sold(5)
|
|
Angus Russell(3)
|
75,033
|
30,342
|
Sylvie Gregoire
|
15,220
|
5,339
|
Jeffrey Jonas
|
2,115
|
633
|
Number of Ordinary Shares released(4)
|
Number of Ordinary Shares sold(6)
|
|
Graham Hetherington(3)
|
100,314
|
52,594
|
Tatjana May
|
28,410
|
14,896
|
(3).
|
The PSA Awards granted in 2010 to Angus Russell and Graham Hetherington were subject to performance conditions measured over the performance period 2010 to 2012. Based on the performance conditions, 100% of the PSA Awards vested.
|
(4).
|
In accordance with the rules of the PSP, the vested PSA awards have been increased to reflect the dividends paid by the Company in the period from the grant date to the vesting date.
|
(6) .
|
Ordinary shares were sold on the London Stock Exchange at an average sale price of £20.76842 each.
|
Investor Relations
|
||
Eric Rojas
|
erojas@shire.com
|
+1 781 482 0999
|
Sarah Elton-Farr
|
seltonfarr@shire.com
|
+44 1256 894157
|
|
·
|
Behavioral Health and Gastro Intestinal conditions
|
|
·
|
Rare Diseases
|
|
·
|
Regenerative Medicine
|